PRPO 5.15 (-7.37%)
US74019L5030Medical Diagnostics & ResearchDiagnostics & Research

Precipio (PRPO) Competitor Comparison

We are evaluating the key criteria listed to compare Precipio (PRPO) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - PRPO ranking 47 / 57

These are the competitors of Precipio in the industry Diagnostics & Research ranked by linearity 10 years
1. Anixa Biosciences ANIX
79.83
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. Inotiv NOTV
18.58
4. Olink Holding OLK
8.11
5. Neogen NEOG
7.12
6. Guardant Health GH
6.69
7. Fulgent Genetics FLGT
6.4
8. NeoGenomics NEO
6.09
9. Illumina ILMN
6
10. Global Cord Blood CO
5.67
11. Pacific Biosciences of California PACB
5.06
12. Qiagen QGEN
4.92
13. DarioHealth DRIO
4.86
14. Exact Sciences EXAS
4.37
15. Syneos Health SYNH
3.71
16. Sotera Health SHC
3.71
17. Bioventus BVS
3.27
18. Co-Diagnostics CODX
3.21
19. Enzo Biochem ENZ
3.08
20. Myriad Genetics MYGN
3.03
21. Charles River Laboratories CRL
2.97
22. Twist Bioscience TWST
2.57
23. Psychemedics PMD
2.5
24. Sera Prognostics SERA
2.48
25. CareDx CDNA
2.34
26. Aspira Womens Health AWH
2.28
27. Exagen XGN
2.27
28. Meridian Bioscience VIVO
2.1
29. Icon ICLR
1.99
30. MDxHealth MDXH
1.92
31. bioAffinity Technologies BIAF
1.9
32. Biodesix BDSX
1.87
33. MaxCyte MXCT
1.82
34. Personalis PSNL
1.8
35. Prenetics Global PRE
1.72
36. Laboratory Corp of America Holdings LH
1.69
37. Organovo Holdings ONVO
1.66
38. IQVIA Holdings IQV
1.63
39. Neuronetics STIM
1.62
40. Trinity Biotech TRIB
1.57
41. Quest Diagnostics DGX
1.51
42. SeqLL SQL
1.42
43. Agilent Technologies A
1.37
44. Interpace Biosciences IDXG
1.33
45. DexCom DXCM
1.25
46. PerkinElmer PKI
1.15
47. Precipio PRPO
1.09
48. Mettler-Toledo MTD
1.06
49. Danaher DHR
1.03
50. Waters WAT
1
51. Thermo Fisher Scientific TMO
0.89
52. IDEXX Laboratories IDXX
0.86
53. Heska HSKA
0.52
54. Natera NTRA
0.41
55. Lantheus Holdings LNTH
0.32
56. RadNet RDNT
0.29
57. Medpace Holdings MEDP
0.22

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.